Bing

SEARCH HISTORY

Code Rebel Corp (CDRB) traded at $16.00 + 11.00 (220.00 pct) on 33,215 total stock volume. The company is — year-to-date, and — during the last 12 months. Giga-tronics Incorporated (GIGA) traded at $3.00 + 0.874 …
Fx Pips · 5/21/2015
total stock volume
CORAL GABLES, Fla., May 28, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today …
Financial Content · 23 hours ago
Catalyst Pharmaceuticals
NEW YORK (TheStreet) -- Catalyst Pharmaceutical Partners (CPRX) shares are up 14.2% to $3.41 on Tuesday after ROTH Capital raised the company's price target to $6 from $5 and reiterated its "buy" rating. The upgraded outlook stems from Catalyst's …
The Street · 9/30/2014
More from Bing News
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) is engaged in developing ... out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300) This is a FREE report from Insider Monkey. Credit Card is NOT required.
INSIDER MONKEY · 12/3/2014
Catalyst Pharmaceutical Partners (NASDAQ:CPRX) Director Charles B. O’keeffe acquired 10,000 shares of the stock on the open market in a transaction that occurred on Thursday, April 30th. The shares were purchased at an average price of $3.29 per …
Ticker Report · 5/1/2015
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >> CATALYST PHARMACEUTICAL PARTNERS (CPRX): Free Stock Analysis Report ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report …
Yahoo Finance · 9/5/2014
Catalyst Pharmaceutical Partners (NASDAQ:CPRX) Director Donald A. Denkhaus bought 15,000 shares of the stock on the open market in a transaction dated Monday, April 27th. The stock was purchased at an average price of $3.71 per share, for a total ...
wkrb13.com · 4/29/2015
PLUS: High Dividend Stocks With Big Yield and Big Growth That greed is continuing ... Catalyst Pharmaceutical Partners (CPRX) is a development-stage company focused on the creation of drugs for diseases and disorders of the nervous system such as ...
NASDAQ · 10/28/2014
Catalyst Pharmaceutical Partners (NASDAQ:CPRX) Director Donald A. Denkhaus acquired 15,000 shares of the stock on the open market in a transaction that occurred on Monday, April 27th. The stock was purchased at an average price of $3.71 per share …
sleekmoney.com · 4/29/2015
Stock analysts at SunTrust initiated coverage on shares of Catalyst Pharmaceutical Partners (NASDAQ:CPRX) in a report issued on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $7.00 price target on the stock.
Intercooler · 2/26/2015